These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 29114876)

  • 21. NO modulation of carotid body chemoreception in health and disease.
    Moya EA; Alcayaga J; Iturriaga R
    Respir Physiol Neurobiol; 2012 Nov; 184(2):158-64. PubMed ID: 22516266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carotid body and cardiorespiratory alterations in intermittent hypoxia: the oxidative link.
    Del Rio R; Moya EA; Iturriaga R
    Eur Respir J; 2010 Jul; 36(1):143-50. PubMed ID: 19996187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carotid body modulation in systolic heart failure from the clinical perspective.
    Niewinski P
    J Physiol; 2017 Jan; 595(1):53-61. PubMed ID: 26990354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hydrogen sulfide restores normal breathing stability and improves autonomic control during experimental heart failure.
    Del Rio R; Marcus NJ; Schultz HD
    J Appl Physiol (1985); 2013 May; 114(9):1141-50. PubMed ID: 23449938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ecto-5'-nucleotidase (CD73) regulates peripheral chemoreceptor activity and cardiorespiratory responses to hypoxia.
    Holmes AP; Ray CJ; Pearson SA; Coney AM; Kumar P
    J Physiol; 2018 Aug; 596(15):3137-3148. PubMed ID: 28560821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age protects from harmful effects produced by chronic intermittent hypoxia.
    Quintero M; Olea E; Conde SV; Obeso A; Gallego-Martin T; Gonzalez C; Monserrat JM; Gómez-Niño A; Yubero S; Agapito T
    J Physiol; 2016 Mar; 594(6):1773-90. PubMed ID: 26752660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of hypoxia-inducible factors in carotid body (patho) physiology.
    Semenza GL; Prabhakar NR
    J Physiol; 2018 Aug; 596(15):2977-2983. PubMed ID: 29359806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guinea Pig as a Model to Study the Carotid Body Mediated Chronic Intermittent Hypoxia Effects.
    Docio I; Olea E; Prieto-LLoret J; Gallego-Martin T; Obeso A; Gomez-Niño A; Rocher A
    Front Physiol; 2018; 9():694. PubMed ID: 29922183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carotid body chemoreceptors: physiology, pathology, and implications for health and disease.
    Iturriaga R; Alcayaga J; Chapleau MW; Somers VK
    Physiol Rev; 2021 Jul; 101(3):1177-1235. PubMed ID: 33570461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carotid body denervation prevents the development of insulin resistance and hypertension induced by hypercaloric diets.
    Ribeiro MJ; Sacramento JF; Gonzalez C; Guarino MP; Monteiro EC; Conde SV
    Diabetes; 2013 Aug; 62(8):2905-16. PubMed ID: 23530003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carotid body potentiation during chronic intermittent hypoxia: implication for hypertension.
    Del Rio R; Moya EA; Iturriaga R
    Front Physiol; 2014; 5():434. PubMed ID: 25429271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carotid Body and Metabolic Syndrome: Mechanisms and Potential Therapeutic Targets.
    Kim LJ; Polotsky VY
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent Hypoxia-Induced Carotid Body Chemosensory Potentiation and Hypertension Are Critically Dependent on Peroxynitrite Formation.
    Moya EA; Arias P; Varela C; Oyarce MP; Del Rio R; Iturriaga R
    Oxid Med Cell Longev; 2016; 2016():9802136. PubMed ID: 26798430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purines and Carotid Body: New Roles in Pathological Conditions.
    Conde SV; Monteiro EC; Sacramento JF
    Front Pharmacol; 2017; 8():913. PubMed ID: 29311923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High fat diet blunts the effects of leptin on ventilation and on carotid body activity.
    Ribeiro MJ; Sacramento JF; Gallego-Martin T; Olea E; Melo BF; Guarino MP; Yubero S; Obeso A; Conde SV
    J Physiol; 2018 Aug; 596(15):3187-3199. PubMed ID: 29271068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin and carotid body chemoreception in heart failure.
    Schultz HD
    Curr Opin Pharmacol; 2011 Apr; 11(2):144-9. PubMed ID: 21242106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carotid Body-Mediated Chemoreflex Drive in The Setting of low and High Output Heart Failure.
    Del Rio R; Andrade DC; Toledo C; Diaz HS; Lucero C; Arce-Alvarez A; Marcus NJ; Schultz HD
    Sci Rep; 2017 Aug; 7(1):8035. PubMed ID: 28808320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carotid body hypersensitivity in intermittent hypoxia and obtructive sleep apnoea.
    Prabhakar NR; Peng YJ; Nanduri J
    J Physiol; 2023 Dec; 601(24):5481-5494. PubMed ID: 37029496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KLF2 mediates enhanced chemoreflex sensitivity, disordered breathing and autonomic dysregulation in heart failure.
    Marcus NJ; Del Rio R; Ding Y; Schultz HD
    J Physiol; 2018 Aug; 596(15):3171-3185. PubMed ID: 29023738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of carotid body chemoreflex dysfunction during heart failure.
    Schultz HD; Marcus NJ; Del Rio R
    Exp Physiol; 2015 Feb; 100(2):124-9. PubMed ID: 25398713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.